1. bookVolume 18 (2017): Issue 1 (March 2017)
Journal Details
License
Format
Journal
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Copyright
© 2020 Sciendo

Review paper. Gluten-related disorders and schizophrenia - potential linking mechanisms, diagnostic and therapeutic challenge

Published Online: 23 May 2017
Page range: 9 - 24
Received: 15 Dec 2016
Accepted: 09 Mar 2017
Journal Details
License
Format
Journal
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Copyright
© 2020 Sciendo

More and more evidence confirms the theory that the intake of cereal products containing gluten may play an important role in the pathogenesis of many diseases. There are also premises indicating the relationship between the so-called gluten-related diseases and the development and course of mental disorders, including schizophrenia.

Keywords

1. Tovoli F., Masi C., Guidetti E., Negrini G., Paterini P., Bolondi L.. Clinical and diagnostic aspects of gluten related disorders. World J Clin Cases. 2015;3(3):275-84.Search in Google Scholar

2. Sapone A., Bai J. C., Ciacci C., Dolinsek J., Green P.H.R., Hadjivassiliou, et al. Spectrum of gluten-related disorders: Consensus on new nomenclature and classification. BMC Med. 2012;10:13.Search in Google Scholar

3. Fasano A., Catassi C. Celiac disease. N Eng J of Med. 2012; 367(25): 2419-2426.Search in Google Scholar

4. Jackson Allen PL.. Guidelines for the diagnosis and treatment of celiac disease in children. Pediatr Nurs. 2004; 30(6): 473-476.Search in Google Scholar

5. Catassi C, Gobellis G. Coeliac disease epidemiology is alive and kicking, especially in the developing world. Dig Liver Dis. 2007;39:908-910.Search in Google Scholar

6. Catassi C., Kryszak D., Louis-Jacques O., Duerksen DR., Hill I., Crowe SE. et al. Detection of Celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol. 2007;102:1454-1460Search in Google Scholar

7. Lebwohl, B., Ludvigsson, J.F., & Green, P.H.R. The unfolding story of celiac disease risk factors. Clin Gastroenterol Hepatol. 2014; 12(4): 632-635.Search in Google Scholar

8. Catassi C., Kryszak, D., Bhatti, B., Sturgeon, C., Helzlsouer, K., Clipp, S.L., Fasano A. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010; 42(7): 530-538.Search in Google Scholar

9. Allen PJ. Gluten-Related Disorders: Celiac Disease, Gluten Allergy, Non-Celiac Gluten Sensitivity. Pediatr Nurs. 2015;41(3):146-50.Search in Google Scholar

10. Troncone, R., & Discepolo, V..Celiac disease and autoimmunity. J Pediatr Gastroenterol Nutr.2014; 59(Suppl. 1):S9-S11Search in Google Scholar

11. Tack G.J., Verbeek W.H.M., Schreurs M.W.J., & Mulder C.J.J. The spectrum of celiac disease: Epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol. 2010; 7(4): 204-213.Search in Google Scholar

12. Rosén A., Sandström O., Carlsson A., Högberg L., Olén O., Stenlund H., & Ivarsson A. Usefulness of symptoms to screen for celiac disease. Pediatrics. 2014;133(2): 211-218.Search in Google Scholar

13. Kaukinen K., Lindfors K., Collin P., Koskinen O., Mäki M.. Coeliac disease-a diagnostic and therapeutic challenge. Clin Chem Lab Med. 2010 ;48(9):1205-16.Search in Google Scholar

14. Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105(12):2520-4Search in Google Scholar

15. Husby S., Koletzko S., Korponay-Szabó I.R., Mearin M.L., Phillips A., Shamir R., Zimmer K.P.. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. RPIA. 2012;20(3): 227-228.Search in Google Scholar

16. Amarri S., Alvisi P., De Giorgio R., Gelli MC., Cicola R., Tovoli F., Sassatelli R., Caio G., Volta U.. Antibodies to deamidated gliadin peptides: an accurate predictor of coeliac disease in infancy. J Clin Immunol. 2013;33(5):1027-30.Search in Google Scholar

17. Zevit N., Shamir R.. Diagnosis of celiac disease: where are we heading after the ESPGHAN 2012 guidelines?. J Pediatr Gastroenterol Nutr. 2014;59 Suppl 1:S13-5.Search in Google Scholar

18. Volta U., Villanacci V.. Celiac disease: diagnostic criteria in progress. Cell Mol Immunol. 2011;8(2):96-102.Search in Google Scholar

19. Hill I.D., Dirks M.H., Liptak G.S., Colletti R.B., Fasano A., Guandalini S., Seidman, E.G.. Guideline for the diagnosis and treatment of celiac disease in children: Recom mendations of the North American society for pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2005; 40(1): 1-19.Search in Google Scholar

20. Husby S., Koletzko S., Korponay-Szabó IR., Mearin ML., Phillips A., Shamir R., et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136-60.Search in Google Scholar

21. Guandalini S., & Vallee P.A.. Pediatric celiac disease. 2010. Retrieved from http://emedicine.medscape.com/article/932104overviewSearch in Google Scholar

22. Elli L., Branchi F., Tomba C., Villalta D., Norsa L., Ferretti F., Roncoroni L., Bardella MT.. Diagnosis of gluten related disorders: Celiac disease, wheat allergy and non-celiac gluten sensitivity. World J Gastroenterol. 2015 ;21(23):7110-9.Search in Google Scholar

23. Vierk KA., Koehler KM., Fein SB., Street DA.. Prevalence of selfreported food allergy in American adults and use of food labels. J Allergy Clin Immunol. 2007;119(6):1504-10.Search in Google Scholar

24. Matricardi PM., Bockelbrink A., Beyer K., Keil T., Niggemann B., Grüber C., Wahn U., Lau S.. Primary versus secondary immunoglobulin E sensitization to soy and wheat in the MultiCentre Allergy Study cohort. Clin Exp Allergy. 2008;38(3):493-500.Search in Google Scholar

25. Ramesh S. Food allergy overview in children. Clin Rev Allergy Immunol. 2008;34(2):217-30Search in Google Scholar

26. Keet CA., Matsui EC., Dhillon G., Lenehan P., Paterakis M., Wood RA. The natural history of wheat allergy. Ann Allergy Asthma Immunol 2009;102(5):410-5. doi: 10.1016/S1081-1206(10)60513-3Search in Google Scholar

27. Catassi C., Elli L., Bonaz B., Bouma G., Carroccio A., Castillejo G., et al. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts' Criteria. Nutrients. 2015;7(6):4966-77.Search in Google Scholar

28. Cooper BT., Holmes GK., Ferguson R., Thompson RA., Allan RN., Cooke WT. Gluten-sensitive diarrhea without evidence of celiac disease. Gastroenterology. 1980; 79: 801-806Search in Google Scholar

29. Digiacomo, D.V., Tennyson, C.A., Green, P.H., & Demmer, R.T. Prevalence of gluten-free diet adherence among individuals without celiac disease in the USA: Results from the continuous national health and nutrition examination survey 2009-2010. Scand J Gastroenterol. 2013; 48(8):921-925.Search in Google Scholar

30. Aziz I., Lewis N.R., Hadjivassiliou M., Winfield S.N., Rugg N., Kelsall A., Nevrick L., Sanders D.S. A UK study assessing the population prevalence of self-reported gluten sensitivity and referral characteristics to secondary care. Eur J Gastroenterol Hepatol . 2014; 26(1): 33-39.Search in Google Scholar

31. Volta U., Bardella MT., Calabrò A., Troncone R., Corazza GR.. Study Group for Non-Celiac Gluten Sensitivity. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med. 2014;12:85.Search in Google Scholar

32. Biesiekierski J.R., Peters S.L., Newnham E.D., Rosella O., Muir J.G., & Gibson P.R. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013; 145(2): 320-328.e1-3.Search in Google Scholar

33. Vazquez-Roque M., Oxentenko AS. Nonceliac Gluten Sensitivity. Mayo Clin. Proc.. 2015; 90(9):1272-7.Search in Google Scholar

34. Lundin K.E.A., & Alaedini A.. Non-celiac gluten sensitivity. Gastrointestinal Gastrointest Endosc Clin N Am. 2012;22(4):723-34.Search in Google Scholar

35. Catassi. C., Bai J.C., Bonaz B., Bouma G., Calabrò A., Carroccio A., Fasano A. Non-celiac gluten sensitivity: The new frontier of gluten related disorders. Nutrients. 2013; 5(10), 3839-3853.Search in Google Scholar

36. Newton KP., Singer SA. Celiac disease in children and adolescents: special considerations. Semin Immunopathol. 2012;34(4):479-96.Search in Google Scholar

37. Kalaydjian AE., Eaton W., Cascella N., Fasano A. The gluten connection: The association between schizophrenia and celiac disease. Acta Psychiatr Scand. 2006; 113:82-90.Search in Google Scholar

38. Graff H., Handford A. Celiac syndrome in the case histories of five schizophrenics. Psychiatr Q. 1961; 35:306-313.Search in Google Scholar

39. Dohan FC., Grasberger JC., Lowell FM., Johnston HT Jr, Arbegast AW. Relapsed schizophrenics: More rapid improvement on a milk- and cereal-free diet. Br J Psychiatry. 1969; 115:595-596.Search in Google Scholar

40. Dohan FC., Grasberger JC. Relapsed schizophrenics: Earlier discharge from the hospital after cereal-free, milk-free diet. Am J Psychiatry. 1973; 130:685-688.Search in Google Scholar

41. De Santis A., Addolorato G., Romito A., Caputo S., Giordano A., Gambassi G., Taranto C., Manna R., Gasbarrini G. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J Intern Med. 1997;242(5):421-3.Search in Google Scholar

42. Cascella NG., Kryszak D., Bhatti B., Gregory P., Kelly DL., Mc Evoy JP., et al. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr Bull. 2011; 37:94-100.Search in Google Scholar

43. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Leister F. et al. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 2010; 68: 100- 104.Search in Google Scholar

44. Samaroo D., Dickerson F., Kasarda DD., Green PH., Briani C., Yolken RH., et al. Novel immune response to gluten in individuals with schizophrenia. Schizophr Res. 2010; 118:248-255.Search in Google Scholar

45. Söderholm J.D., and Perdue M.H. II.Stress and intestinal barrier function. Am J Physiol. Gastrointest Liver Physiol. 2001; 280:G7-G13.Search in Google Scholar

46. Collins SM., Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136(6):2003-14.Search in Google Scholar

47. Lambert GP. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J Anim Sci. 2009;87(14 Suppl):E101-8.Search in Google Scholar

48. Jong A, Huang SH. Blood-brain barrier drug discovery for central nervous system infections. Curr Drug Targets Infect Disord. 2005;5(1):65-72.Search in Google Scholar

49. Laterra J., Keep R., Betz LA., and Goldstein GW. Blood- Cerebrospinal Fluid Barrier In Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition. Siegel GJ, Agranoff BW, Albers RW, editors. Philadelphia: Lippincott-Raven; 1999.Search in Google Scholar

50. Clemente MG., De Virgiliis S., Kang JS., Macatagney R., Musu MP., Di Pierro MR., Drago S., Congia M., Fasano A. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut. 2003;52(2):218-23.Search in Google Scholar

51. Thomas KE., Sapone A., Fasano A., Vogel SN. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease. J Immunol. 2006 ;176(4):2512-21.Search in Google Scholar

52. Lammers KM., Lu R., Brownley J., Lu B., Gerard C., Thomas K., Rallabhandi P., Shea-Donohue T., Tamiz A., Alkan S., Netzel-Arnett S., Antalis T., Vogel SN., Fasano A. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 2008;135(1):194-204.e3.Search in Google Scholar

53. Tripathi A., Lammers KM., Goldblum S., Shea-Donohue T., Netzel- Arnett S., Buzza MS., Antalis TM., Vogel SN., Zhao A., Yang S., Arrietta MC., Meddings JB., Fasano A. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci USA. 2009;106(39):16799-804. doi: 10.1073/pnas.0906773106.Search in Google Scholar

54. Buscaino V. Patologia extraneurale della schizofrenia. Fegato, tubo digerente, sistema reticolo endoteliale. Acta Neurol. 1953; 8: 1-60.Search in Google Scholar

55. Hemmings G. Schizophrenia. Lancet 2004; 364(9442): 1312-1313.Search in Google Scholar

56. Severance EG., Gressitt KL., Stallings CR., Origoni AE., Khushalani S., Leweke FM. et al. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr. Res. 2013; 148(1-3): 130-137.Search in Google Scholar

57. Mortensen PB., Nørgaard-Pedersen B., Waltoft BL., Sørensen TL., Hougaard D., Yolken RH. Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull. 2007;33(3):741-4.Search in Google Scholar

58. Torrey EF., Bartko JJ., Lun ZR., Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a metaanalysis. Schizophr Bull. 2007;33(3):729-36.Search in Google Scholar

59. Yolken RH., Dickerson FB., Fuller Torrey E. Toxoplasma and schizophrenia. Parasite Immunol. 2009;31(11):706-15. doi: 10.1111/j.1365-3024.2009.01131Search in Google Scholar

60. Severance EG., Kannan G., Gressitt KL., Xiao J., Alaedini A., Pletnikov MV., Yolken RH. Anti-gluten immune response following Toxoplasma gondii infection in mice. PLoS One. 2012;7(11):e50991Search in Google Scholar

61. Nemani K et al.. Schizophrenia and the gut-brain axis. Prog Neuro-Psychoph. 2015; 56:155-166.Search in Google Scholar

62. Hornig M, The role of microbes and autoimmynity in the pathogenesis of neuropsychiatric illness. Curr. Opin. Rheumatol. 2013; 25(4): 488-795.Search in Google Scholar

63. Cryan JF., Dinan TG.. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-12.Search in Google Scholar

64. Caminero A., Herrán AR., Nistal E., Pérez-Andrés J., Vaquero L., Vivas S. et al. .Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease. EMS Microbiol Ecol. 2014;88(2):309-19.Search in Google Scholar

65. Hong S.N. and Rhee P. L. Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J. Gastroenterol. 2014; 20: 2470-2481.Search in Google Scholar

66. Kau AL., Ahern PP., Griffin NW., Goodman AL., Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474(7351):327-36. .Search in Google Scholar

67. David LA., Maurice CF., Carmody RN., Gootenberg DB., Button JE., Wolfe BE et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 23;505(7484):559-63.Search in Google Scholar

68. Brown K., DeCoffe D., Molcan E., Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012; 4: 1095-1119Search in Google Scholar

69. Severance E.G., Prandovszky E., Castiglione J., Yolken R.H. Gastroenterology issues in schizophrenia: why the gut matters Curr Psychiatry Rep. 2015; 17(5): 27Search in Google Scholar

70. Kostic A.D., Xavier R.J., Gevers D. The Microbiome in Inflammatory Bowel Diseases: Current Status and the Future Ahead. Gastroenterology. 2014 ; 146(6): 1489-1499.Search in Google Scholar

71. Gevers D., Kugathasan S., Denson LA., Vázquez-Baeza Y., Van Treuren W., Ren B., Schwager E. et al. The treatment-naïve microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;12: 15(3): 382-392.Search in Google Scholar

72. Diaz Heijtz R., Wang S., Anuar F., Qian Y., Björkholm B., Samuelsson A., Hibberd ML., Forssberg H., Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108(7):3047-52.Search in Google Scholar

73. Clarke G1, Grenham S., Scully P., Fitzgerald P., Moloney RD., Shanahan F., Dinan TG, Cryan JF. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 2013;18(6):666-73.Search in Google Scholar

74. Sudo N., Chida Y., Aiba Y., Sonoda J., Oyama N., Yu XN. et al.. Postnatal microbial colonization programs the hypothalamicpituitary- adrenal system for stress response in mice. J. Physiol. 2004; 558: 263-275.Search in Google Scholar

75. Dickerson FB., Stallings C., Origoni A., Katsafanas E. et al. Effect of Probiotic Supplementation on Schizophrenia Symptoms and Association With Gastrointestinal Functioning: A Randomized, Placebo-Controlled Trial Prim Care Companion CNS Disord. 2014; 16(1): pii: PCC.13m01579. doi: 10.4088/PCC.13m01579.Search in Google Scholar

76. Severance EG., Dickerson FB., Halling M., Krivogorsky B., Haile L., Yang S. et al. Subunit and whole molecule specificity of the antibovine casein immune response in recent onset psychosis and schizophrenia. Schizophr Res. 2010;118(1-3):240-7.Search in Google Scholar

77. Fernandez-Feo M., Wei G., Blumenkranz G., Dewhirst FE., Schuppan D., Oppenheim FG. et al. The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity. Clin Microbiol Infect. 2013 ;19(9):E386-94.Search in Google Scholar

78. Zioudrou C., Streaty R.A., Klee W.A. Opioid peptides derived from foodproteins.Theexorphins.J.Biol.Chem. 1979;254:2446-2449.Search in Google Scholar

79. Teschemacher H. Opioid receptor ligands derived from food proteins. Curr.Pharm.Des. 2003; 9:1331-1344.Search in Google Scholar

80. Bressan P., Kramer P.. Bread and Other Edible Agents of Mental Disease. Front Hum Neurosci. 2016;10:130.Search in Google Scholar

81. Margules D.L. β-endorphinandendoloxone: hormonesoftheautonomic nervous system for the conservation or expenditure of bodily resources and energy inanticipation off amineorfeast. ActaDiabetol. 1979; 3:155-162.Search in Google Scholar

82. Margules D. L. ‘‘Energy balance and opioid receptors: epsilons in the periphery promote conservation; κ and δ in the CNS permit expenditures,’’ in The Eating Disorders: Medical and Psychological Bases of Diagnosis and Treatment, eds B.J. Blinder ,B.F. Chaitinand R.S. Goldstein.New York, NY: PMA Publishing. 1988;21-27.Search in Google Scholar

83. Yeomans M. R., and Gray R. W. Opioid peptides and the control of human ingestive behaviour. Neurosci. Biobehav. Rev. 2002;26:713-728.Search in Google Scholar

84. Kostyra E., Sienkiewicz-Szlapka E., Jarmolowska B., Krawczuk S., and Kostyra H.. Opioid peptides derived from milk proteins. Pol. J. Food Nutr. Sci. 2004; 13:25-35.Search in Google Scholar

85. Miner-Williams W. M., Stevens B. R., and Moughan P. J..Are intact peptides absorbed from the healthy gut in the adult human? Nutr. Res. Rev. 2014;27:308-329.Search in Google Scholar

86. Ulluwishewa D., Anderson R. C., McNabb W. C., Moughan P. J., Wells J. M., and Roy N. C. Regulation of tight junction permeability by intestinal bacteria and dietary components. J. Nutr. 2011;141:769-776.Search in Google Scholar

87. Purohit V., Bode J.C., Bode C., Brenner D.A., Choudhry M.A., Hamilton F., et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin and medical consequences: summary of a symposium. Alcohol. 2008; 42:349-361.Search in Google Scholar

88. Smale S., and Bjarnason I. Determining small bowel integrity following drug treatment. Br. J. Clin. Pharmacol. 2003; 56:284-291.Search in Google Scholar

89. Hemmings W.A. The entry into the brain of large molecules derived from diet ary protein.Proc.R.Soc.Lond.B.Biol.Sci. 1978;200:175-192.Search in Google Scholar

90. Sun Z., and Cade J. R. A peptide found in schizophrenia and autism causes behavioral changes in rats. Autism. 1999; 3:85-95.Search in Google Scholar

91. Meisel H., and FitzGerald R. J. Opioid peptides encrypted in intact milk protein sequences. Br. J. Nutr. 2000;84:S27-S31.Search in Google Scholar

92. Hole K., Bergslien H., Jørgensen H. A., Berge O. G., Reichelt K. L., and Trygstad O. E. A peptide-containing fraction in the urine of schizophrenic patients which stimulates opiate receptors and inhibits dopamine uptake. Neuroscience 1979; 4: 1883-1893.Search in Google Scholar

93. Drysdale A., Deacon R., Lewis P., Olley J., Electricwala A., and Sherwood R. A peptide-containing fraction of plasma from schizophrenic patients which binds to opiate receptors and induces hyper-reactivity in rats. Neuroscience. 1982;7:1567-1573.Search in Google Scholar

94. Sokolov O., Kost N., Andreeva O., Korneeva E., Meshavkin V., Tarakanova Y., et al. Autistic children display elevated urine levels of bovine casomorphin-7 immunoreactivity. Peptides. 2014;56: 68-71.Search in Google Scholar

95. Cass H., Gringras P., March J., McKendrick I., O’Hare A. E., Owen L., et al. Absence of urinary opioidpeptides In children with autism. Arch.Dis. Child. 2008;93:745-750.Search in Google Scholar

96. Sun Z., Cade J. R., Fregly M. J., and Privette R. M. βCasomorphin induces Fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism. Autism 1999; 3: 67-83.Search in Google Scholar

97. Cade R., Privette M., Fregly M., Rowland N., Sun Z. J., Zele V., et al. Autism and schizophrenia: intestinal disorders. Nutr. Neurosci. 2000;3: 57-72.Search in Google Scholar

98. Genuis S.J., and Lobo R. A. Gluten sensitivity presenting as a neuropsychiatric disorder. Gastroenterol. Res. Pract. 2014:ID 293206. http://dx.doi.org/10.1155/2014/293206Search in Google Scholar

99. Lister J., Fletcher P. J., Nobrega J. N., and Remington G. Behavioral effects of food-derived opioid-like peptides in rodents: implications for schizophrenia? Pharmacol Biochem Behav. 2015;134:70-8.Search in Google Scholar

100. Emrich HM., Cording C., Pirée S., Kölling A., von Zerssen D., Herz A. Indication of an antipsychotic action of the opiate antagonist naloxone. Pharmakopsychiatr Neuropsychopharmakol. 1977;10(5):265-70Search in Google Scholar

101. Gillberg C., Terenius L., and Lönnerholm G. Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases. Arch. Gen. Psychiatry. 1985:42:780-783.Search in Google Scholar

102. Lindström L. H., Besev G., Gunne L. M., and Terenius L. CSF levels of receptor-active endorphins in schizophrenic patients: correlations with symptomatology and monoamine metabolites. Psychiatry Res. 1986; 19: 93-100.Search in Google Scholar

103. Lindström LH., Nyberg F., Terenius L., Bauer K., Besev G., Gunne LM., Lyrenäs S., Willdeck-Lund G., Lindberg B. CSF and plasma beta- casomorphin-like opioid peptides in postpartum psychosis. Am J Psychiatry. 1984;141(9):1059-66Search in Google Scholar

104. Severance EG., Gressitt KL., Alaedini A., Rohleder C., Enning F., Bumb JM., Müller JK., Schwarz E., Yolken RH., Leweke FM. IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia. Brain Behav Immun. 2015;44:148-58.Search in Google Scholar

105. Newton KP., Singer SA. Celiac disease in children and adolescents: special considerations. Semin Immunopathol. 2012;34(4):479-96.Search in Google Scholar

106. Food and Drug Administration, HHS. Food labeling: gluten-free labeling of foods. Final rule. Fed Regist. 2013 Aug 5;78(150):47154-79.Search in Google Scholar

107. Potkin SG., Weinberger D., Kleinman J., Nasrallah H., Luchins D., Bigelow L., Linnoila M., Fischer SH., Bjornsson TD., Carman J., Gillin JC., Wyatt RJ.: Wheat gluten challenge in schizophrenic patients. Am J Psychiatry 1981; 138(1208):11.Search in Google Scholar

108. Arroll MA., Wilder L., Neil J.. Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review. Nutr J. 2014 ; 16:13:91Search in Google Scholar

109. Jackson J., Eaton W., Cascella N., Fasano A., Warfel D., Feldman S., Richardson C., Vyas G., Linthicum J., Santora D., Warren KR., Carpenter WT. Jr, Kelly DL.. A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr Res. 2012;140(1-3):262-3.Search in Google Scholar

110. Lurie Y., Landau DA., Pfeffer J., Oren R. Celiac disease diagnosed in the elderly. J Clin Gastroenterol. 2008 ;42(1):59-61.Search in Google Scholar

111. De Santis A., Addolorato G., Romito A., Caputo S., Giordano A., Gambassi G., et al. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: Regression after a gluten-free diet. Journal of Internal Medicine. 1997; 242:421-423.Search in Google Scholar

112. Eaton WW., Chen LY., Dohan FC. Jr, Kelly DL., Cascella N. Improvement in psychotic symptoms after a gluten-free diet in a boy with complex autoimmune illness. Am J Psychiatry. 2015;172(3):219-21.Search in Google Scholar

113. Lionetti E., Leonardi S., Franzonello C., Mancardi M., Ruggieri M., Catassi C. Gluten Psychosis: Confirmation of a New Clinical Entity. Nutrients. 2015;7(7):5532-9.Search in Google Scholar

114. Hollon J.R., Cureton P.A., Martin M.L., Puppa E.L.L., & Fasano A. Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients. BMC Gastroenterology. 2013;13(1).Search in Google Scholar

115. Dewar DH., Donnelly SC., McLaughlin SD., Johnson MW., Ellis HJ., Ciclitira PJ. Celiac disease: management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol. 2012;18(12):1348-56.Search in Google Scholar

116. Mukherjee R., Kelly CP., Schuppan D. Nondietary therapies for celiac disease. Gastrointest Endosc Clin N Am. 2012;22(4):811-31Search in Google Scholar

117. Stoven S., Murray JA., Marietta E. Celiac disease: advances in treatment via gluten modification. Clin Gastroenterol Hepatol. 2012;10(8):859-62 Search in Google Scholar

Plan your remote conference with Sciendo